Puma Biotechnology (PBYI)
(Delayed Data from NSDQ)
$5.02 USD
+0.14 (2.87%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $5.01 -0.01 (-0.20%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth C Momentum A VGM
Earnings News For PBYI
-
What's in Store for Puma Biotechnology (PBYI) in Q1 Earnings?
-
Earnings Preview: Puma Biotech (PBYI) Q1 Earnings Expected to Decline
-
Puma Biotechnology (PBYI) Q4 Earnings & Revenues Lag Estimates
-
Puma Biotech: Q4 Earnings Snapshot
-
Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results
-
Puma Biotechnology (PBYI) to Report Q4 Earnings: What's in Store?
-
Puma Biotech (PBYI) Q3 Earnings Beat, Revenues Lag Estimates
-
Puma Biotech (PBYI) Tops Q3 Earnings Estimates
-
Puma Biotech: Q3 Earnings Snapshot
-
Puma Biotechnology Reports Third Quarter 2023 Financial Results
-
Puma Biotech (PBYI) Q2 Earnings Beat, Nerlynx Sales Outperform
-
Puma Biotech (PBYI) Surpasses Q2 Earnings and Revenue Estimates
-
Puma Biotechnology Reports Second Quarter Financial Results
-
Puma Biotech (PBYI) Q1 Earnings Beat, Nerlynx Sales Rise Y/Y
-
Puma Biotech: Q1 Earnings Snapshot
-
Puma Biotech (PBYI) Q1 Earnings and Revenues Top Estimates
-
Puma Biotechnology Reports First Quarter Financial Results
-
Puma Biotech (PBYI) Q4 Loss Wider Than Expected, Sales Top
-
Puma Biotech: Q4 Earnings Snapshot
-
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results
-
Puma Biotech (PBYI) Q3 Earnings Top, Nerlynx Sales View Up
-
Puma Biotech (PBYI) Reports Q3 Loss, Tops Revenue Estimates
-
Puma Biotech: Q3 Earnings Snapshot
-
Puma Biotechnology Reports Third Quarter 2022 Financial Results
-
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat